Home Tags IMGC936

Tag: IMGC936

ImmunoGen to Prioritize Continued Development of Mirvetuximab Soravtansine

Peter Hofland
Waltham, Massachusetts, based ImmunoGen, expanding field of antibody-drug conjugates (ADCs) with the development of the next generation of targeted anti-cancer agents, has completed an...

ADVERTISE WITH US

FEATURED RESOURCES

ADC Review, Journal of Antibody-drug Conjugates
MADE POSSIBLE BY:
ADCBIO
Lonza
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policy makers.

News

Peer Review Articles

© 2013-2019 Sunvalley Communication, LLC. All Rights Reserved.